Angiotensin-receptor blockers, hypertension and alzheimer disease: The entangled relationship

Circulation Journal

Volumn 77, Issue 2, 2013, Pages 315-316

  Katayama, Takayuki ^a   Hasebe, Naoyuki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL PLUS CHLORTALIDONE; CANDESARTAN; DONEPEZIL; ENALAPRIL MALEATE PLUS NITRENDIPINE; GALANTAMINE; INDAPAMIDE PLUS PERINDOPRIL; MEMANTINE; RIVASTIGMINE; TELMISARTAN;

ALZHEIMER DISEASE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HUMAN; HYPERTENSION; MINI MENTAL STATE EXAMINATION; RISK;

ALZHEIMER DISEASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE;

EID: 84873846114     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1550     Document Type: Editorial

References (15)

1. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunizationwith amyloid-beta peptide: A case report. Nat Med 2003; 9: 448-452.
2. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: A retrospective analysis. Lancet Neurol 2012; 11: 241-249.
3. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's disease: Clinical trials and drug development. Lancet Neurol 2010; 9: 702-716 (erratum Lancet Neurol 2011; 10: 501).
4. Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J 2011; 75: 1042-1048.
5. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Arch Neurol 2003; 60: 223-228.
6. Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 2012; 322: 141-147.
7. Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, et al. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 2009; 54: 782-787.
8. Hsu CY, Huang CC, Chan WL, Huang PH, Chiang CH, Chen TJ, et al. Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population: A nationwide cohort study. Circ J 2013; 77: 405-410.
9. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst- Eur) trial. Lancet 1998; 352: 1347-1351.
10. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069-1075.
11. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154-2160.
12. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-886.
13. Saxby BK, Harrington F, Wesnes KA, McKeith IG, Ford GA. Candesartan and cognitive decline in older patients with hypertension: A substudy of the SCOPE trial. Neurology 2008; 70: 1858-1866.
14. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: A double-blind, active and placebo-controlled study. Lancet Neurol 2008; 7: 875-884 (erratum Lancet Neurol 2008; 7: 985).
15. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683-689.